Two IPOs are scheduled to raise $1.3 billion in the week ahead. While the IPO calendar is relatively quiet at the moment, several issuers could launch, including pool equipment supplier Hayward Holdings (HAYW) and crafts-focused...read more
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. The IPO pipeline remained active as well, with 3 IPOs and 38 SPACs submitting initial filings. ...read more
Pharvaris, a Phase 1 biotech developing oral small molecule therapies for rare diseases, raised $165 million by offering 8.3 million shares at $20, above the range of $17 to $19. The company sold 19% more shares than originally anticipated. The...read more
16 IPOs are set to make this the busiest week for the US IPO market since December 2006.
Driven by faster IPO timelines and momentum from last year, 2021 is positioning itself to be a banner year for the IPO market, and this latest milestone joins a growing...read more
US IPO Week Ahead: Health insurer Oscar Health leads a 2 IPO week
Two IPOs are scheduled to raise $1.3 billion in the week ahead. While the IPO calendar is relatively quiet at the moment, several issuers could launch, including pool equipment supplier Hayward Holdings (HAYW) and crafts-focused...read more
US IPO Weekly Recap: Biotechs flood the IPO market in a 14 IPO week
The IPO market had its busiest week yet this year with 14 IPOs raising $3.9 billion and 27 SPACs raising $9.2 billion. The IPO pipeline remained active as well, with 3 IPOs and 38 SPACs submitting initial filings. ...read more
Rare disease biotech Pharvaris prices upsized US IPO above the range at $20
Pharvaris, a Phase 1 biotech developing oral small molecule therapies for rare diseases, raised $165 million by offering 8.3 million shares at $20, above the range of $17 to $19. The company sold 19% more shares than originally anticipated. The...read more
February starts off with the busiest week for US IPOs in over a decade
16 IPOs are set to make this the busiest week for the US IPO market since December 2006. Driven by faster IPO timelines and momentum from last year, 2021 is positioning itself to be a banner year for the IPO market, and this latest milestone joins a growing...read more